Business Wire

IQM Quantum Computers Unveils Development Roadmap Focused on Fault-tolerant Quantum Computing by 2030

Share

IQM Quantum Computers (IQM), a global leader in superconducting quantum computing, today announced its development roadmap with technical milestones targeting fault tolerant quantum computing by 2030, while enabling a dedicated Noisy Intermediate-Scale Quantum (NISQ) approach for near-term usage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241113963297/en/

IQM Quantum Computers Development Roadmap (Graphic: Business Wire)

Since its start, IQM has successfully delivered full-stack quantum computers based on its first three processor generations. IQM's 12-year roadmap reflects its vision for pioneering quantum solutions through novel algorithmic approaches, modular software integration, and scalable hardware advancements. It leverages the company's ability to design and fabricate next-generation quantum processors with seamless integration into full-stack systems controlled by an open software stack.

IQM's unique co-design capabilities steer the roadmap towards efficient error-correction implementations with high system performance by merging IQM's two processor topologies IQM Star and IQM Crystal. To enable the roadmap, IQM systematically invests in its R&D, testing and fabrication facilities to boost technology scaling up to 1 million qubits while maintaining high qubit quality and gate fidelity.

To support the developer community and to ease the usage of quantum computing, IQM will also enable tight high-performance computing (HPC) integration and create a special software development kit (SDK). Open interfaces will empower the ecosystem, including quantum error mitigation, co-develop libraries and use-cases on IQM’s quantum computers.

The company aims to achieve quantum advantage across multiple industry domains, focusing on quantum simulations, optimization, and quantum machine learning. According to a McKinsey report, these selected use-cases will unlock a value potential of more than US$28 billion by 2035.

Quantum advantage will be provided by fully error-corrected systems with hundreds to thousands of high-precision logical qubits, for which error correction will be enabled by efficiently implementing novel quantum low-density parity-check (QLDPC) codes. This approach reduces the hardware overhead by a factor of up to 10 compared to surface code implementation.

Furthermore, IQM is targeting high-precision logical qubits with error rates below 10^-7, enabling quantum advantage for applications demanding exceptional accuracy, such as in chemistry and materials science.

“We are implementing Quantum low-density parity-check (QLDPC) codes through a novel chip topology, enabled by our uniquely connected Star topology, long-distance couplers and a very compact approach for advanced packaging and signal routing,” said Dr. Jan Goetz, Co-Founder and Co-CEO of IQM Quantum Computers. “This underlines our commitment to hardware efficiency, enabling a feasible and scalable pathway to fault tolerance combined with an open and modular software architecture.”

Goetz emphasizes that the company’s proprietary cleanroom facilities will support the fabrication of complex processors with unique long-range connections, facilitating high-performance quantum processors.

To this end, IQM will implement novel solutions for advanced packaging and 3D integration to ensure scalability while maintaining its ambitious goals to reduce error rates, while its large-scale processors will be built up in a modular way and powered by cryogenic electronics. The results are reduced heat load, strongly miniaturized packaging solutions, and reduced cost per qubit. These features will result in more performant and affordable products for IQM's customers in the HPC and enterprise market.

Offering on-premises and cloud access, IQM has been specializing in integrating quantum systems into HPC centers since 2020. The latest is Germany’s first hybrid quantum computer at the Leibniz Supercomputing Centre.​

IQM aims to explain further details of the roadmap in future publications, blog posts, and at industry and academic events.

About IQM Quantum Computers:

IQM is a global leader in designing, building, and selling superconducting quantum computers. IQM provides both on-premises full-stack quantum computers and a cloud platform to access its computers anywhere in the world. IQM customers include the leading high-performance computing centres, research labs, universities and enterprises which have full access to IQM's software and hardware. IQM has over 280 employees with offices in Espoo, Madrid, Munich, Paris, Palo Alto, Singapore and Warsaw.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241113963297/en/

Contacts

Email: press@meetiqm.com
Mobile: +358504790845
www.meetiqm.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.meetiqm.co
m%2F&esheet=54152085&newsitemid=20241113963297&lan=en-US&anchor=www.meetiqm.com&
index=2&md5=0e164a7e428807f4e256044fee302953

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press Release

Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans

Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press Release

The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa

ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press Release

ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an

Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press Release

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai

Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye